Filter by: patients
Home > Community Treatment Reports and Side Effects > Helidac Treatment Report
What is Helidac?

Helidac® is a brand name product that combines bismuth subsalicylate, metronidazole, and tetracycline. It is used as part of a multidrug regimen for H. pylori eradication to reduce the risk of duodenal ulcer recurrence in combination with an H2 agonist.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Other 1 1 Efficacy_major
Duodenal Ulcer 1 0

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 0
Moderate
 0
Mild
 1
None
 0

Commonly reported side effects, conditions, and hospitalizations associated with Helidac

Cryptosporidial diarrhea 1

Reported Stop Reasons

Why Patients Stopped Taking Helidac (multiple reasons could be selected)
Reason # Patients Percentage of patients
Course of treatment ended 1   Course of treatment ended: 100%

See all 1 patient who’ve stopped taking Helidac

Reported Duration See details about how long patients take this treatment ▼

Stopped Taking Helidac

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Helidac

Always
 1 100%
Usually
 0 0%
Sometimes
 0 0%
Never
 0 0%

Burden

Difficulty being on treatment

Burden of Helidac

Very
 0 0%
Somewhat
 0 0%
A little
 0 0%
Not at all
 1 100%

Cost

Paid out of pocket

Cost of Helidac

$200+
 0 0%
$100-199
 0 0%
$50-99
 0 0%
$25-49
 0 0%
< $25
 0 0%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 27, 2012.